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Abstract
The aim of this chapter is to present a literature review on some of the main 
articles describing different interventions for the treatment in patients with pro-
gressive intractable Ménière disease symptoms. Even though each paper presents 
good results in defending its techniques, there have been few well-designed clini-
cal studies, that is, studies involving control groups or long-term observation, in 
the efficacy of surgery with respect to vertigo control and hearing preservation. 
Focusing on presenting the different techniques established in the literature, we dis-
cuss the main indications and results obtained regarding the control of vertigo and 
the audiological outcomes after the procedure. Physicians should offer additional 
treatment strategies for Meniere’s disease patients with a long history of limiting 
symptoms or associated hearing loss. The surgical options for such patients should 
be considered carefully because surgery can damage the ipsilateral ear and the 
hearing function of the contralateral ear is often suboptimal. Its importance is that 
alternatives for treatment can only be offered to a patient when doctor knows them.
Keywords: Ménière’s disease, hearing loss, vertigo, endolymphatic sac, vestibular 
rehabilitation
1. Introduction
Ménière’s disease is a clinical diagnosis based on the 1995 classification by 
the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) 
Committee on Hearing and Equilibrium [1]. The definitive diagnosis of Ménière’s 
disease can be made with specific tests such as audiometry and electrocochleography 
in the exacerbated states of the disease. Recently, a study by Bernaerts [2] showed 
diagnostic evidences with the use of magnetic resonance imaging (MRI) scans, which 
showed an enlargement of the perilymphatic spaces in Ménière’s disease.
The endolymphatic sac physiologically maintains the hydrostatic pressure and 
endolymph homeostasis in the inner ear, and its dysfunction may contribute to the 
pathophysiology of Ménière’s disease. The classic tetrad of symptoms in endolym-
phatic hydrops includes recurrent attacks of vertigo lasting for hours, fluctuating 
hearing loss, auricular fullness, and tinnitus. Ménière’s disease is idiopathic, as 
its aetiology remains unknown. Over the years, different surgical procedures 
for intractable vertigo secondary to Ménière’s disease have been carried out, and 
although many authors consider these procedures effective, some argue that they 
only have a placebo effect. Usually, surgical procedures are indicated in about 20% 
of the patients when the possibilities of treatment with drugs for vestibular reha-
bilitation have already been exhausted [3–6].
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The surgical technique for the treatment of vertigo depends on the diagnostic 
hypothesis, clinical condition, age, and hearing level of the patient.
2. Conservative procedures for Ménière’s disease
This chapter describes the different surgical procedures performed for Ménière’s 
disease. They can be divided into two types: non-destructive surgery, aimed at alter-
ing the disease expression and at reducing the frequency and intensity of vestibular 
drop attacks; and destructive surgery, aimed at controlling vertigo by stopping the 
vestibular function.
The most common procedures are the endolymphatic sac decompression with 
or without the endolymphatic duct opening and shunt in the endolymphatic sac, 
endolymphatic duct blockage, and intratympanic corticosteroid injection.
2.1 Endolymphatic sac decompression and shunt in the endolymphatic sac
Decompression of the endolymphatic sac involves reducing pressure in this 
space. It is considered a conservative procedure because of the low rate of hearing 
loss and the high success rate (around 80% or more) of vertigo control [7, 8].
The first surgical procedure for the treatment of Ménière’s disease was described 
in 1927 by Portmann [9, 10], who first opened the endolymphatic sac to decrease the 
endolymphatic pressure. In 1938, Hallpike and Cairns [11] showed the pathological 
findings of endolymphatic hydrops in post-mortem temporal bones of patients who 
were also diagnosed with Ménière’s disease. These bones showed signs of ischemia 
in the sensory terminal endings at the lateral walls of the membranous labyrinth, 
which could have been caused by the presence of hydrops.
In 1962, William House [12] showed that draining endolymphatic hydrops using 
a subarachnoid shunt had good outcomes. In 1967, Kimura [13] obliterated the endo-
lymph duct and attenuated the endolymphatic hydrops in guinea pigs, following which 
surgeons innovated new techniques of mastoid shunts. In 1976, Paparella [14] described 
a technique that emphasised the need to make a wide incision in the dura mater of the 
posterior fossa to completely decompress the endolymphatic sac and duct, increasing its 
drainage through a valve created in this duct with the placement of a T-tube.
Paparella described that this surgical technique was a modification of the surgi-
cal technique of the endolymphatic sac described by Portmann and showed a 94% 
control rate for vertigo [15].
In a 2014 meta-analysis conducted by Sood et al. [16], the various endolym-
phatic surgical techniques were analysed, along with their efficacy in vertigo 
control and hearing maintenance. The study demonstrated that the decompression 
procedures of the endolymphatic sac both alone and associated with shunt place-
ment in the mastoid were effective, without any statistical difference in the 75% 
control of vertigo symptoms in a short period of 12–24 months.
Bento et al. [17] conducted a retrospective study of endolymphatic sac decom-
pression using the retrolabyrinthine approach in 95 patients with Ménière’s disease 
who did not undergo long-term clinical treatment. In the group with unilateral 
disease, vertigo was controlled in 94.3%, cochlear function significantly improved 
in 14%, and hearing was preserved or improved in 88% of patients. In the group 
with bilateral disease, vertigo was controlled in 85.7%, cochlear function improved 
in 28%, and auditory function was preserved in 71% of patients. Considerable 
improvement in hearing was an improvement of more than 20 dB in the bone 
conduction threshold or improvement by more than 20% in the discrimination 
score (Figures 1 and 2).
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The surgical method of endolymphatic sac decompression and drainage of the 
endolymphatic duct, as previously described by Paparella et al. [18–20], involves 
a broad exposure of the mastoid cortex, wall-up mastoidectomy, and extensive 
removal of the pre-sigmoidal and retrolabyrinthine cells.
A very thin skeletal bone should cover the sigmoid sinus, and a small bone 
island should be left over it to avoid damage from pressure and bleeding. With the 
Trautmann’s triangle fully exposed, the overlying bone is removed with a curette 
or microdissector, and the sac is then identified as a dense white thickening in the 
dura mater pointing toward the lower portion of the posterior semicircular canal. 
Mostly, the sac is clearly differentiated from the adjacent dura mater by its greater 
thickness in the region and lack of blood vessels. After identifying the endolym-
phatic sac, a small aperture is created in it with a paracentesis blade or a scalpel, 
often below the bone border, by retracting the dura mater with a suction tip to 
expose the lumen. To keep the opening intact, a T-shaped silastic sheet is cut to 
about 0.127 mm thickness and positioned in the opening, or a T-tube is used. After 
the procedure, an absorbable gelatine haemostatic sponge is placed in the mastoid 
cavity, and the wound is closed.
2.2 Endolymphatic duct block
In this technique, the sac is not incised. The surgeon dissects the bone around 
the endolymphatic duct to expose it and blocks it with two small titanium clips. 
Figure 1. 
The sac is opened (arrowhead).
Figure 2. 
A silastic sheet (arrow) is placed to keep the sac opened.
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The endolymphatic sac gets isolated, so the production and absorption of endo-
lymph in the inner ear balance. Saliba et al. [21] conducted a randomised con-
trolled, non-blinded study comparing this technique with the endolymphatic sac 
decompression and showed that 96.5% of the patients in the endolymphatic block 
group achieved vertigo control compared to 37.5% of the patients in the endolym-
phatic sac decompression group, with no statistical differences between the groups 
in pre- and post-operative auditory thresholds.
In summary, endolymphatic duct blockade has potential as a surgical technique 
that results in good control of vertigo.
2.3 Corticosteroid therapy
In 1986, Brookes [22] showed the presence of high levels of circulating immuno-
complexes in up to 54% of patients with Ménière’s disease. Later, Alleman et al. [23] 
extracted the circulating immunocomplexes from patients with Ménière’s disease 
and exposed them to endolymphatic sac tissue from other patients with the dis-
ease, showing that in only 10% of cases, there was a reaction between the immune 
complexes and tissues. Hence, it is suggested that although the levels of circulating 
immunocomplexes in these patients is high, they can represent an induction (viral, 
allergic, or traumatic) that is greater than an autoimmune phenomenon. Another 
pathophysiological analysis of Ménière’s disease showed that the immune-mediated 
responses in the inner ear, endolymphatic sac, and vascular striae could be the main 
causative factors. In 1997, Shea et al. [24] showed that combined administration 
of systemic and intratympanic dexamethasone completely suppressed vertigo in 
63.4% and significantly improved hearing in 35.4% of patients within 2 years after 
treatment. Later in 2001, Sennaroglu et al. [25] reported that intratympanic perfu-
sion of dexamethasone completely suppressed vertigo in 42.0% and significantly 
improved hearing in 16% of patients within 2 years after treatment.
3. Destructive surgeries for Ménière’s disease
These labyrinthine surgeries cure the patient of vertigo by destroying the final 
vestibular organ. The brain compensates for the loss of vestibular function on 
one side using the contralateral labyrinth, as long as it is functioning properly. 
Destructive labyrinthine procedures have a high risk of destroying the cochlea 
and should be avoided in patients with adequate hearing. Vestibulocochlear nerve 
neurectomy, chemical labyrinthectomy, surgical labyrinthectomy, and sacculotomy 
are common destructive surgeries.
3.1 Vestibulocochlear nerve neurectomy
The neurectomy of the vestibulocochlear nerve for the treatment of Ménière’s 
disease was described in 1933 by Dandy [26]. It is a surgical technique involving a 
selective section of the vestibular nerve at its entrance to the brain to reduce vertigo 
but inevitably causing total hearing loss in the operated ear.
Several authors modified the original technique. In 1989, Silverstein [27] 
proposed the retrosigmoid approach for neurectomy and observed a substantial 
improvement in dizziness in 92% with a significant hearing loss in only 4% of 
patients.
House [28] introduced the middle fossa approach. Regardless of the access, the 
decompression technique had a success rate of up to 90% in the control of vertigo 
[29–33]. Colletti et al. [4] conducted a comparative study on 209 patients who 
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underwent neurectomy, comparing a group of 24 patients who received intratym-
panic gentamicin (ITG), chemical labyrinthectomy neural ablation therapy. To 
perform a homogenous comparison of results in the present paper, it considered all 
the 24 ITG patients and the last 24 patients who underwent VN from 2000 to 2002 
via the retrosigmoid approach.
Vertigo was controlled in 95.8% of neurectomy patients and in 75% of gentami-
cin patients. Speech discrimination in the neurectomy group was reduced from 85 to 
82% and in the gentamicin group from 87% to 65%.
3.2  Chemical labyrinthectomy: intratympanic application of gentamicin in the 
middle ear
This technique was first used in 1978 by Beck [34, 35] and aims to perform 
a chemical ablation of the labyrinth to decrease the frequency and intensity of 
vertigo episodes but can result in hearing loss, as gentamicin is ototoxic and reduces 
labyrinthine activity. It can be injected directly into the tympanic cavity using a thin 
needle or applied daily through a Politzer ventilation tube first placed at the tym-
panic membrane for penetrating the round and oval windows. A study [36] showed 
90% efficacy in the cessation of vertigo among 92 patients.
In the 2000 literature review by Blakley et al. [37], 18 articles were found on the 
techniques of intratympanic injection of gentamicin in the treatment of Ménière’s 
disease. The articles reported high success rates in vertigo treatment, but the tech-
nique, dose, duration, and treatment philosophy varied considerably among them. 
Hearing loss was typically reported in about 30% of patients, and no technique 
had any significant medical advantage over the other. Until new controlled studies 
indicate otherwise, this therapy is an alternative treatment for patients with major 
comorbidities.
3.3 Surgical labyrinthectomy
This technique can decrease vertigo by the total destruction of the labyrinth but 
leads to total hearing loss in the operated ear.
Lake first described this procedure in 1904 [38], and in the mid-twentieth 
century, labyrinthectomy was established as a less-invasive alternative to neurec-
tomy of the vestibular nerve [39, 40]. The surgical technique involves opening the 
semicircular canals up to the endolymphatic ducts in the opening of the vestibule 
with the complete destruction of neuroepithelium and Scarpa’s ganglion [41, 42]. 
No technique was observed to be superior in vertigo control among labyrinthec-
tomy, neurectomy, and a combination of both [43, 44].
Labyrinthectomy, in particular, is an alternative [45] (demonstrating approxi-
mately 100% success rate in vertigo treatment) for old patients, and in this case, 
the transmastoid technique presented a lower permanent imbalance rate after 
the procedure than the transcanal technique. Labyrinthectomy is the treatment 
of choice for patients over 60 years of age [46]. Surgical labyrinthectomy of the 
affected labyrinth always ends in total deafness. Therefore, it should be reserved 
for patients with non-functional hearing and should be one of the last therapeutic 
options (Figure 3).
3.4 Sacculotomy
In 1964, Fick [47, 48] described a procedure in which a fenestra is made in the 
stapes footplate or round window membrane, and therefore, a permanent shunt for 
draining of the saccule is created with the destruction of the cochlear function [49].
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Giddings et al. [50] reported hearing loss after cochleo-sacculotomy in 80% 
of the patients and recurrent vertigo episodes in a mean follow-up of 17 months 
in 4 of 11 patients so that a destructive intervention had to be carried out again. 
Kinney et al. [51] and Wielinga et al. [52] recommended cochleo-sacculotomy as 
a minimally invasive surgical method, especially for old patients, as an alternative 
to neurectomy because good results were obtained with regard to vertigo control, 
although with significant hearing loss in almost all patients.
In 2015, in a comparative study [53] between cochlear sacculotomy techniques 
and endolymphatic sac decompression, the control of vertigo was significantly 
better in patients after cochleo-sacculotomy but also with significant deteriora-
tion of hearing. The cochleo-sacculotomy procedure performed simultaneously 
with cochlear implant surgery in patients with deafness and persistent vertigo in 
Ménière’s disease is an alternative already proposed by some authors [54–56], and 
they have reported good results.
4. Conclusion
The surgical procedures described in this chapter demonstrated satisfactory 
results in the control of incapacitating vertigo in patients diagnosed with endolym-
phatic hydrops refractory to clinical drug treatment, adequate diet, and vestibular 
rehabilitation. The choice of method would depend on the quality of residual hear-
ing, contralateral hearing, and on the ability to develop compensatory mechanisms 
if surgical techniques destroyed vestibular function.
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Figure 3. 
Schematic drawing of Labyrinthectomy.
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